We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TNDM market cap is 1.85B. The company's latest EPS is USD -3.3895 and P/E is -8.31.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 185.62M | 196.8M | 191.67M | 221.91M | 243.97M |
Operating Income | -31.55M | -35.06M | -41.68M | -28.77M | -26.09M |
Net Income | -32.96M | -30M | -42.72M | -30.81M | -23.25M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 362.31M | 498.83M | 702.8M | 801.22M | 747.72M |
Operating Income | -16.72M | -7.96M | 22.65M | -92.85M | -233.23M |
Net Income | -24.75M | -34.38M | 15.57M | -94.59M | -222.61M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 939.91M | 952.66M | 941.05M | 937.5M | 957.73M |
Total Liabilities | 625.91M | 639.03M | 697.98M | 703.63M | 720.02M |
Total Equity | 314M | 313.63M | 243.06M | 233.88M | 237.71M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 326.11M | 716.42M | 905.14M | 1.05B | 952.66M |
Total Liabilities | 131.13M | 350.11M | 472.03M | 612.84M | 639.03M |
Total Equity | 194.98M | 366.31M | 433.11M | 439.95M | 313.63M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -24.59M | -31.81M | -8M | -13.27M | 13.51M |
Investing | -69.16M | -85.74M | -5.06M | -8.6M | -28.49M |
Financing | 1.5M | 4.11M | 13.59M | 10.58M | 6.07M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 41.91M | 24.67M | 111.36M | 50.46M | -31.81M |
Investing | -56.96M | -296.06M | -186.88M | 33.17M | -85.74M |
Financing | 24.21M | 314.44M | 51.93M | 16.88M | 4.11M |
Market Cap | 1.85B |
Price to Earnings Ratio | -8.31 |
Price to Sales Ratio | 2.47 |
Price to Cash Ratio | 31.42 |
Price to Book Ratio | 5.9 |
Dividend Yield | - |
Shares Outstanding | 65.68M |
Average Volume (1 week) | 1.6M |
Average Volume (1 Month) | 1.65M |
52 Week Change | 58.47% |
52 Week High | 53.69 |
52 Week Low | 17.33 |
Spread (Intraday) | 0.07 (0.25%) |
Company Name | Tandem Diabetes Care Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.tandemdiabetes.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions